You've used all available free searches this month | for more free features.
Clincosm LogoSign in Get a demo

marginal zone B cell lymphoma

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HNSCC, Melanoma, Gynecologic Cancer Trial in Portland (DP CD8 TIL, DP CD8 TIL KD, Low dose IL-2)

Recruiting
  • HNSCC
  • +5 more
  • DP CD8 TIL
  • +2 more
  • Portland, Oregon
    Providence Portland Medical Center
Jun 5, 2023

Kidney Cancer Trial in Houston (Axitinib)

Active, not recruiting
Has Results
  • Kidney Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 2, 2022

Non-squamous NSCLC, EGFR Gene Mutation Trial in Chengdu (Tislelizumab Combined With Bevacizumab and Platinum Plus Pemetrexed)

Not yet recruiting
  • Non-squamous Non-small Cell Lung Cancer
  • EGFR Gene Mutation
  • Tislelizumab Combined With Bevacizumab and Platinum Plus Pemetrexed
  • Chengdu, Sichuan, China
  • +2 more
May 24, 2022

Small-cell Lung Cancer Trial in Worldwide (Berzosertib, Topotecan)

Active, not recruiting
  • Small-cell Lung Cancer
  • Santa Rosa, California
  • +47 more
Jun 24, 2022

Acute Lymphoblastic Leukemia, Pediatric Trial in Giza (Balance exrcises, Balance exrcises and Treadmill training)

Completed
  • Acute Lymphoblastic Leukemia, Pediatric
  • Balance exrcises
  • Balance exrcises and Treadmill training
  • Giza, Cairo, Egypt
  • +1 more
Nov 12, 2021

Mycosis Fungoides, Cutaneous T-Cell Lymphoma, Tumors Trial run by the NCI (Romidepsin (FR901228))

Terminated
  • Mycosis Fungoides
  • +2 more
  • Romidepsin (FR901228)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 14, 2019

Hemophilia B Trial in United Kingdom, United States (Gene Transfer, scAAV2/8-LP1-hFIXco)

Active, not recruiting
  • Hemophilia B
  • Stanford, California
  • +7 more
Nov 17, 2022

Fistula in Ano, Crohn Disease Trial in Rochester (MSC-AFP)

Recruiting
  • Fistula in Ano
  • Crohn Disease
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Mar 30, 2022

Mitapivat in Subjects With Sickle Cell Disease

Enrolling by invitation
  • Sickle Cell Anemia
  • +7 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Small Cell Lung Cancer, Extra-Pulmonary Small Cell Carcinomas Trial run by the NCI (PLX038, Rucaparib)

    Active, not recruiting
    • Small Cell Lung Cancer
    • Extra-Pulmonary Small Cell Carcinomas
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Esophageal Squamous Cell Carcinomas Trial (PF regimen (cis-platinum ; 5-fluorouracil ) combined with PD-1

    Not yet recruiting
    • Esophageal Squamous Cell Carcinomas
    • PF regimen (cis-platinum ; 5-fluorouracil ) combined with PD-1 inhibitors（pembrolizumab）
    • (no location specified)
    Nov 1, 2021

    Oropharyngeal Dysphagia Trial in Sacramento, San Francisco (Autologous Muscle Derived Cells for Gastro-Intestinal Repair

    Recruiting
    • Oropharyngeal Dysphagia
    • Autologous Muscle Derived Cells for Gastro-Intestinal Repair (AMDC-GIR)
    • Placebo
    • Sacramento, California
    • +1 more
    Jun 13, 2022

    Dental Prosthesis Failure Trial in Göteborg (High-translucent monolithic zirconia Bridge, Zirconium oxide ceramics Framework,

    Recruiting
    • Dental Prosthesis Failure
    • High-translucent monolithic zirconia Bridge
    • +2 more
    • Göteborg, Sweden
      B R Å N E M A R K C L I N I C
    Mar 24, 2022

    Advanced Non Small Cell Lung Cancer Trial run by the National Cancer Institute (NCI) (aerosolized aztreonam, aerosolized

    Not yet recruiting
    • Advanced Non Small Cell Lung Cancer
    • aerosolized aztreonam
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Mar 28, 2023

    Sickle Cell Disease Trial in Atlanta (Arginine, Arginine (Loading), Arginine (Continuous))

    Recruiting
    • Sickle Cell Disease
    • Atlanta, Georgia
    • +1 more
    Apr 22, 2022

    Carcinoma, Renal Cell Trial in New York (Spartalizumab, Canakinumab)

    Recruiting
    • Carcinoma, Renal Cell
    • New York, New York
      Columbia University Medical Center
    May 6, 2022

    Multiple Myeloma Trial in New York (Tremelimumab, Durvalumab, Prevnar-13)

    Terminated
    Has Results
    • Multiple Myeloma
    • New York, New York
    • +1 more
    Oct 3, 2022

    HFNC and NIV for COVID-19 Complicated by Respiratory Failure

    Completed
    • Respiratory Failure
    • HFNC
    • Hong Kong, Hong Kong
      Prince of Wales Hospital
    Jul 21, 2022

    Congenital Bleeding Disorder, Haemophilia A With Inhibitors, Haemophilia B With Inhibitors Trial in Worldwide (Concizumab,

    Completed
    Has Results
    • Congenital Bleeding Disorder
    • +2 more
    • Los Angeles, California
    • +21 more
    Sep 24, 2021

    Measures (PROMs) in Adoptive Cell Therapy (ACT) Setting

    Not yet recruiting
    • Cancer
      • (no location specified)
      Feb 7, 2023

      Nivolumab in Squamous Cell Carcinoma of Head & Neck - Patient

      Completed
      • Squamous Cell Carcinoma of the Head and Neck
      • Nivolumab
      • Mount Laurel, New Jersey
        Local Institution
      May 2, 2022

      COVID-19, Critical Illness, Hypercytokinemia Trial in Ulm (Application of exosomes in a whole blood assay)

      Recruiting
      • COVID-19
      • +3 more
      • Application of exosomes in a whole blood assay
      • Ulm, Germany
        Ulm University Hospital, Clinic of Anesthesiology and Intensive
      Jan 17, 2022

      Muscular Dystrophies, Congenital Myopathy, Idiopathic Inflammatory Myopathies Trial in Paris (Lower-limb powered dermoskeleton)

      Recruiting
      • Muscular Dystrophies
      • +4 more
      • Lower-limb powered dermoskeleton
      • Paris, France
        Institute of Myology
      Mar 28, 2022

      Vitamin D Deficiency, Vitamin D Insufficiency Trial in Boston (UVB treatment, Sham comparator)

      Recruiting
      • Vitamin D Deficiency
      • Vitamin D Insufficiency
      • UVB treatment
      • Sham comparator
      • Boston, Massachusetts
        BU School of Medicine
      Mar 28, 2022

      irAE Prediction of Anti-PD-1/L1 in Lung Cancer

      Recruiting
      • Immune Checkpoint Inhibitors
      • Lung Cancer
        • Beijing, China
          Peking Union Medical College Hospital
        Mar 31, 2022